World Leukemia Day is a day about promoting diagnosis and raising awareness of the disease. At Servier, as part of our commitment to contributing to the fight against rare cancers, we are working to see the lives of patients with leukemia transformed.
A global campaign in support of improving diagnosis
To mark World Leukemia Day 2025, a global awareness campaign has been run in collaboration by patient groups from across the globe. Its purpose is to raise awareness of leukemia and educate the world on the signs and symptoms of this condition, to help leukemia patients get diagnosed.
On the Servier side: Transforming the lives of people affected by leukemia
In oncology, we aim to develop precision therapies with a transformative clinical benefit to cancer patients’ lives. We aim to become a focused and innovative player in the treatment of rare cancers, including hematologic cancers (acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and lymphomas).
Our strategy focuses primarily on developing targeted therapies for patient populations with specific mutations.
In May 2025, we acquired all global rights to BN104 from Chinese biotech company BioNova Pharmaceuticals. This precision therapy holds best-in-class potential for acute types of leukemia. This acquisition will further bolster Servier’s leadership in hematologic cancers and commitment to advancing precision medicine as set forth in our 2030 strategy.
Ever mindful of meeting patient needs, our teams are stepping up initiatives to actively involve patients and the associations that represent them. To this end, we are collaborating with the international patient coalitionALAN (Acute Leukemia Advocates Network), and we are supporting the CCI Europe’s projects (Childhood Cancer International Europe).
FAQs – Frequently Asked Questions
What is acute myeloid leukemia (AML)?
AML is a cancer of the blood and bone marrow that progresses rapidly if left untreated.
How is AML contracted?
For most people with AML, there is no apparent reason for the onset of the disease. Acute myeloid leukemia is not a communicable disease.
What are risk factors for AML?
Repeated exposure to benzene (cigarette smoke) is a potential risk factor, as it damages the DNA of normal bone marrow cells.
What is acute lymphoblastic leukemia (ALL)?
Acute lymphoblastic leukemia is a rare cancer that affects bone marrow and affects mainly children.
What are the symptoms of ALL?
To date, there are no known causes of acute lymphoblastic leukemia, and no specific symptoms are linked to the disease.
What grounds for hope for patients with ALL?
In recent years, treatment of acute lymphoblastic leukemia has made considerable progress, which has resulted in high recovery rates, particularly in children.